Dear LBank users,
LBank will list FTM and RDNT USDT-M perpetual contracts at 08:30 on October 23, 2023 (UTC). Details are as follows:
Trade FTM/USDT perpetual contract at: https://www.lbank.com/futures/ftmusdt/
Trade RDNT/USDT perpetual contract at: https://www.lbank.com/futures/rdntusdt/
| Trading pair | Leverage | Tick Size | Funding Fee Settlement Frequency |
| FTMUSDT | 1~50X |
0.0001USDT
|
Every Eight Hours |
|
RDNTUSDT
|
1~20X |
0.0001USDT
|
Every One Hour |
* Based on market risk conditions, LBank may adjust the specifications of the FTMUSDT and RDNTUSDT Perpetual Contracts from time to time, which include the funding fee, tick size, maximum leverage, initial margin, and/or maintenance margin requirements.
Further Information:
- A Beginner’s Guide To Futures Trading (App)
- A Beginner’s Guide To Futures Trading（Web）
- Trading Rules of UST-M Futures Contracts
- Leverage and Margin of Perpetual Futures Contracts
- How to Select Trading Pairs
- LBank Futures Fee Structure
- Mark Price in Perpetual Futures Contract
LBank Community
Telegram | Twitter | Facebook | Discord | Medium | LinkedIn
Click here to download for iOS or Android
If you have problems, please contact LBank official email: service@lbank.info, and we will provide sincere, friendly and immediate service. We also welcome you to join LBank official English community to discuss the latest issue (Telegram): https://t.me/LBank_en.
Risk Warning: Investing in digital assets is extremely risky. Digital asset prices are subject to high market risk and price volatility. The value of your investment may go down or up, and you may not get back the amount invested. You are solely responsible for your investment decisions and LBank is not liable for any losses you may incur. Past performance is not a reliable predictor of future performance. This material shall not be construed as financial advice in any case. LBank reserves the right in its sole discretion to amend or change or cancel this announcement at any time and for any reason without prior notice.
Comments
0 comments
Article is closed for comments.